Skip to content

CAPSTONE® Spinal System 2991126Recalls & reported problems

Medtronic Sofamor Danek, Inc. · SPACER 2991126 CAPSTONE PEEK 11X26 · Class 2 · Implant

Data updated Oct 13, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00613994387387), received between Sep 10, 2020 and Jun 19, 2024 — classified as 2 injuries, 1 malfunction.

The most frequently reported specific device problem is “Break” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 1 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 1 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem2
  • Break1
  • Mechanics Altered1

Patient problems

  • Extraskeletal ossification1
  • No Known Impact Or Consequence To Patient1
  • Pain1
  • Seroma1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • InjuryJun 19, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    INFORMATION WAS RECEIVED FROM A HEALTHCARE PROFESSIONAL (HCP) VIA A MEDTRONIC REPRESENTATIVE REGARDING A PATIENT WITH CLINICAL ID (B)(4) AND STUDY ID (B)(4) . IT WAS REPORTED THAT THE PATIENT COMPLETED A CT SCAN ON (B)(6) 2022. THE SURGEON REVIEWED THE SAME ON (B)(6) 2022 AND NOTICED LEFT-SIDED ECTOPIC BONE GROWTH WHICH COULD POTENTIALLY BE IMPACTING THE PATIENT'S LEFT LEG PAIN. THE PATIENT'S IMPLANTS ARE INTACT AND SHE APPEARS TO BE SOLIDLY FUSED IN THE INTERBODY SPACE. THE PATIENT DISCUSSED POTENTIALLY TRYING A TRANSFORAMINAL STEROID INJECTION AT THE L5-S1 SEGMENT WITH THE SURGEON. DIAGNOSTICS: MRI WITHOUT CONTRAST ON (B)(6) 2022 ; RESULTS- SOLIDLY FUSED IN THE INTERBODY SPACE; LEFT- SIDED ECTOPIC BONE GROWTH. SPONSOR ASSESSMENT: SPONSOR ASSESSED NOT RELATED TO STUDY PROCEDURE ; POSSIBLY RELATED TO TLIF GRAFTING MATERIAL ; UNLIKELY RELATED TO CAPSTONE PEEK SPINAL SYSTEM AND POSTERIOR SUPPLEMENTAL FIXATION SYSTEM. PRIMARY DIAGNOSIS: STENOSIS UPDATE RECEIVED: DESCRIPTION- LEFT-SIDED ECTOPIC BONE GROWTH AT L5-S1 OUTCOME STATUS- UNKNOWN NARRATIVE- AE INVOLVES LEVEL L5-S1 SEVERITY OF AE- MODERATE SITE RELATED ASSESSMENT- UNLIKELY RELATED TO CAPSTONE PEEK AND TLIF GRAFTING MATERIAL, NO

    Patient problems: Extraskeletal ossification

    MAUDE report 19565158 ↗
  • InjuryDec 19, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ADDITIONAL INFORMATION WAS RECEIVED THAT ADVERSE EVENT INFO: DOES THE ADVERSE EVENT INVOLVE A LUMBOSACRAL SPINAL LEVEL: YES, IF YES, LEVELS INVOLVED: L5-S1 ADD SURGICAL PROCEDURE DATE - 01: (B)(6) 2023. DETAILS SURGICAL PROCEDURE - 01: FLUID ASPIRATION AT L5/S1 IS THE ADDITIONAL SURGICAL PROCEDURE AN ELECTIVE REMOVAL - 01: NO DOES THE ADDITIONAL SURGICAL PROCEDURE INVOLVE A SPINAL LEVEL - 01: YES ADD. SURGERY: IF YES, LEVELS INVOLVED - 01: L5-S1 DOES THE ADDITIONAL SURGICAL PROCEDURE INVOLVE AN EXPLANT RELATED TO THE STUDY PROCEDURE - 01: NO SITE RELATED ASSESSMENT: IT IS NOT RELATED TO CAPSTONE PEEK SPINAL SYSTEM, POSTERIOR SUPPLEMENTAL FIXATION SYSTEM, TLIF GRAFTING AND CAUSAL RELATED TO TRANSFORAMINAL INTERBODY LUMBAR FUSION (TLIF) PROCEDURE AT L5/S1. ADDITIONAL INFORMATION WAS RECEIVED THAT INTERVENTIONS : ACTION SUBTYPE: AE RESULT IN HOSPITALIZATION ACTION RESULT: NO ACTION SUBTYPE: ANY OTHER ACTION(S) TAKEN ACTION RESULT: YES OTHER ACTION TAKEN: MRI ORDERED ACTION SUBTYPE: DID THE AE RESULT IN ANY TREATMENT ACTION RESULT: YES ACTION SUBTYPE: DRUG THERAPY ACTION RESULT: YES ACTION SUBTYPE: INJECTION ACTION RESULT: YES INJECTION-1: INJECTION NAME: FACET STEROID INJECTION DATE:

    Patient problems: Pain; Seroma

    MAUDE report 18353688 ↗
  • MalfunctionSep 10, 2020Break; Mechanics Altered; Break; Mechanics Altered

    INFORMATION WAS RECEIVED FROM A HEALTHCARE PROVIDER (HCP) VIA MANUFACTURER REPRESENTATIVE REGARDING A PATIENT WITH LUMBAR DISC HERNIATION FOR POSTERIOR LUMBAR DECOMPRESSION AND FUSION. IT WAS REPORTED THAT THE SCREW THREAD OF THE HOLDING PART WAS BROKEN, AND THE WIRE SLIPPED. PRODUCT CAME IN CONTACT WITH PATIENT. DEVICE EXPLANTED AND WILL BE RETURNED. THERE WERE NO PATIENT SYMPTOMS OR COMPLICATIONS AS A RESULT OF THIS EVENT.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 10512647 ↗

Other Intervertebral fusion device with bone graft, lumbar devices

All Intervertebral fusion device with bone graft, lumbar devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page